WTC
ANRO icon

WhitTier Trust Company’s Alto Neuroscience ANRO Stock Holding History

WhitTier Trust Company’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.8K Hold
2,482
– – ﹤0.01% 693
2026
Q1 		$55.9K Hold
2,482
– – ﹤0.01% 703
2025
Q4 		$37.4K Hold
2,482
– – ﹤0.01% 764
2025
Q3 		$17.1K Hold
2,482
– – ﹤0.01% 931
2025
Q2 		$5.46K Hold
2,482
– – ﹤0.01% 1199
2025
Q1 		$5.34K Hold
2,482
– – ﹤0.01% 1172
2024
Q4 		$10.5K Buy
+2,482
New +$15.5K ﹤0.01% 1058

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

WhitTier Trust Company's ANRO Position: Q2 2026 in Review

WhitTier Trust Company held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 2,482 shares worth $63.8K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

WhitTier Trust Company first reported a position in ANRO in Q4 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • WhitTier Trust Company held 2,482 shares of Alto Neuroscience worth $63.8K as of Q2 2026.
  • WhitTier Trust Company left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #693 holding.
  • WhitTier Trust Company first reported a position in Alto Neuroscience in Q4 2024 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.